Browse diseases

…Background Oxaliplatin resistance is a major obstacle in colorectal cancer (CRC) treatment. While aberrant DNA methylation contributes to …

…Background Colorectal cancer (CRC), the third most prevalent malignancy globally, faces ther…

… which Agathobacter rectalis (Ar) suppresses the progression of colorectal cancer.Methods We analyzed fecal metagenomes from CRC patients and con…

…Introduction Colonoscopy with polypectomy is central to colorectal cancer prevention through the removal of benign polyps prior to malign…

…and routine blood parameters, was recently developed to improve CRC risk stratification and therefore prioritisation of patients fo…

…performance characteristics of FIT at a cut-off of 10μgHb/g for colorectal cancer.Methods Using linked health records from the Secure Anonymised …

…nt risk of metachronous second primary malignancies, especially colorectal cancer, in patients with GEP-NET. The incidence figures may support th…

…associated with upper GI cancer following a positive FIT and no colorectal cancer, inflammatory bowel disease or polyps on lower GI investigation…

…Introduction Accurate real-time optical characterisation of colorectal polyps during colonoscopy is essential for optimal management and colo…

…he mean psoas muscle density was 34 ± 9.6 HU (range 14.1–53.2). Myosteatosis was diagnosed in 52% of patients (n=40) and was statistically a…

…Background Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.…

…s and 2 had polyps. One patient was subsequently diagnosed with coeliac disease.Conclusion Colitis/ileitis represented the most common finding …